Narvitas Presentation March 2015
-
Upload
narvitas-medical-devices-ltd -
Category
Healthcare
-
view
52 -
download
2
Transcript of Narvitas Presentation March 2015
Corporate PresentationMarch 2015
Clinical Problems
• Initial Laparoscopic Access using a Veress needle has not changed in 30 years
• Complications rates are frequent and very expensive
• Time to insufflation!
Opportunity
• Simple innovation to allow safe and fast access to abdomen
• 15 million Laparoscopic procedures using Veress needle every year (extrapolated from available market data).
• Growing 8.3% per annum• Distributor friendly, single use device
Solution – ‘LapDome’• Clinical superiority
• Improves current standard of care • Improves patient safety
• Improved insufflation rates
• Reduced operating theatre budgets
• Reducing potential complications rates
Narvitas Medical Devices • Develop, patent, manufacture and sell proprietary medical
devices• 3 Initial Platforms, each leveraging the core technology• Class 1 - Large market segment – High Volume procedures
Laparoscopic Epidural Anesthesia Med Surg
15 mil procedures worldwide
130 mil births In dwelling catheter collection
EpiDome Jaws
Management Team
Glenn Foley Co-Founder & Dire CEO
AVE – Medtronic -
Precision Vascular
Daragh Sharkey Co-Founder & Director Sales
Mkt and Bus Dev
Aerogen, Altana, Trojan Med
Arthur Malvett Co-Founder & Director
Chief Operating Officer Life
Care Medical, Midland Bank
Medical Advisory Board
• Dr. Aidan Sharkey – Consultant Anesthetist UCHG – Specialty OBGYN
• Dr. Una Conway– Consultant OBGYN – Specialty in Laparoscopic Surgery
• Dr. Michael O’Dowd– Retired Consultant OBGYN – Pioneered Laparoscopic Surgery in UK / Ireland Author of 3
medical texts and numerous research papers
Advisors• Mr. Jerome Nathan
– Former CFO Centellax Corp, LLB University Paris, ACCA University Paris• Mr. Alan Crean
– CEO Poly Pico Medical, CEO Pointec Medical, Director Creganna
Professional Advisors
€452kSubscribed
€298kOpen
€2.3mValuation
Intellectual PropertyLaparoscopic SurgeryNational Phase Patent Application Number Patent Publication Number
US 13/640,015 US2013-0197315A1
Europe 10849757.9 EP2558006A1
Japan P2013-504347 P2013-523370A
Australia 2010351314 AU2010351314A1
South Korea 10-2012-7029658 10-20-130076816
UK GB1408740.7
Epidural AnesthesiaUK GB1409553.3
Distributor Strategy - EMEA
• UK, Ireland, Benelux Q2 – key hospitals and doctors identified
• Key distributors identified – specific expertise in GYN medical devices
• Clinical Backup
• Enterprise Ireland support and back up – key meetings, distributor selection
• Strategic focus on UAE / Saudi Arabia
Distributor Strategy - USA• US Laparoscopic Surgery Veress based procedure volume: 6,000,000 procedures
Surgical Principals Inc Active Medical EA Medical AMSCCS Surgical Adler InstrumentsMediflex USA
Support Programs• Europe/ME referral centers• White papers• Registry• Published papers• Economic Impact analysis
Product Pipeline and TimingDevice Class CE FDA JMOH
I CQI 2015 CQ4 2015 CQI 2016
2A Kits inc Veress CQ4 2015 CQ2 2016 CQ4 2016
EpiDome
CQ3 2015
CQ4 2015
CQI 2016
CQ1 2016
CQ1 2016
CQ3 2016
CQ2 2016
CQ2 2016
CQ4 2016
Financial Forecast
FY2015* FY2016** FY2017***
Sales Revenue €0 €1,585 €9,721
CGS €0 €287 €2,149
GP €0 €1,261 €7,419
OPEX €-232 €459 €1,116
EBITDA €-238 €802 (52%) €6,375 (66%)
* Europe** Europe +US + Latin America*** Europe +US + Latin America + Japan
Liquidity and Exit